Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Deferred Tax Liability (2022)

Gossamer Bio's Non-Current Deferred Tax Liability history spans 1 years, with the latest figure at $1.8 million for Q4 2022.

  • For Q4 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.8 million; the TTM value through Dec 2022 reached $1.8 million, changed N/A, while the annual FY2022 figure was $1.8 million, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability reached $1.8 million in Q4 2022 per GOSS's latest filing.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q4 2022 to a low of $1.8 million in Q4 2022.